P. Morand

Y. Yazdanpanah, C. Londner, B. Fantin, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The Nuclear and Adherent Junction Complex Component Protein Ubinuclein Negatively Regulates the Productive Cycle of Epstein-Barr Virus in Epithelial Cells

P. Morand, H. Gruffat, V. Boyer, 2010, Journal of Virology.

Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.

J. Seigneurin, S. Fafi-Kremer, P. Morand, 2007, Journal of virological methods.

Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.

K. Brengel-Pesce, O. Genoulaz, J. Seigneurin, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study

S. Bertrais, S. Hercberg, K. Ezzedine, 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1

C. Müller, W. Hammerschmidt, C. Petosa, 2021, Nucleic acids research.

Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.

V. Calvez, N. Dupin, I. Gorin, 2004, AIDS research and human retroviruses.

Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient.

V. Maréchal, O. Genoulaz, J. Seigneurin, 1999, Leukemia & lymphoma.

Re: Errors in the Editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670–1672]

L. Farinelli, H. Hartung, M. Clerici, 2013, Multiple sclerosis.

Disseminated Rhinovirus C8 Infection with Infectious Virus in Blood and Fatal Outcome in a Child with Repeated Episodes of Bronchiolitis

B. Lina, L. Kaiser, I. Schuffenecker, 2015, Journal of Clinical Microbiology.

Ultra-deep pyro-sequencing of NS3 to predict response to triple therapy with

J. Claude, R. Beugnot, S. Larrat, 2014 .

Comparison of Serum Hepatitis C Virus (HCV) RNA and Core Antigen Levels in Patients Coinfected with Human Immunodeficiency Virus and HCV and Treated with Interferon plus Ribavirin

F. Carrat, S. Pol, S. Fafi-Kremer, 2006, Journal of Clinical Microbiology.

Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos)

M. Castellazzi, S. Aho, P. Morand, 2009, Biology of the cell.

EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD

G. Salles, A. Fischer, É. Oksenhendler, 2017 .

phase 2 study lymphoproliferative disorders: results of a prospective multicenter Efficacy and safety of rituximab in B-cell post-transplantation

G. Salles, A. Fischer, É. Oksenhendler, 2011 .

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

F. Carrat, S. Pol, P. Cacoub, 2008, Journal of hepatology.

Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016

M. Baccard, P. Morand, O. Epaulard, 2017, PloS one.

HIV-1 Load Comparison Using Four Commercial Real-Time Assays

R. Écochard, P. André, B. Pozzetto, 2010, Journal of Clinical Microbiology.

Transient infection of astrocytes with HIV-1 primary isolates derived from patients with and without AIDS dementia complex.

K. Brengel-Pesce, J. Seigneurin, P. Morand, 1997, Journal of neurovirology.

Potentialities of a mesoporous activated carbon as virus detection probe in aquatic systems.

L. Duclaux, L. Reinert, P. Azaïs, 2022, Journal of virological methods.

Development of an Epstein–Barr virus type 2 (EBV-2)-associated hepatic B cell non-Hodgkin's lymphoma in an HIV-1-infected patient following a change in the EBV dominant type

J. Seigneurin, M. Buisson, M. Péoc'h, 1999, Leukemia.

Serologic and genetic characterization of HIV type 1 subtypes on Reunion Island.

K. Brengel-Pesce, J. Seigneurin, A. Michault, 1999, AIDS research and human retroviruses.

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

J. Seigneurin, S. Larrat, V. Leroy, 2010, Journal of medical virology.

Monitoring Rotavirus Environmental Contamination in a Pediatric Unit Using Polymerase Chain Reaction

M. Mallaret, B. Gratacap-Cavallier, O. Genoulaz, 1999, Infection Control & Hospital Epidemiology.

Association between hepatitis E and neurological disorders: two case studies and literature review.

M. Vaillant, J. Brion, P. Pavèse, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.

J. Seigneurin, S. Fafi-Kremer, M. Joannes, 2008, The Journal of molecular diagnostics : JMD.

Guillain-Barré syndrome related to SARS-CoV-2 infection

L. Kremer, J. de Seze, P. Morand, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Expression, purification, crystallization and preliminary X-ray analysis of a C-terminal fragment of the Epstein-Barr virus ZEBRA protein.

C. Müller, C. Petosa, P. Morand, 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.

D. Costagliola, N. Mounier, F. Bonnet, 2019, AIDS.

Hodgkin lymphoma in the modern combined antiretroviral therapy era

D. Costagliola, N. Mounier, F. Bonnet, 2019 .

Description of an influenza outbreak in a French university hospital and risk factors of nosocomial influenza

M. Mallaret, C. Landelle, J. Bosson, 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD

M. Buisson, G. Socié, J. Dantal, 2017, Scientific Reports.

Structure des enzymes de réplication du virus Epstein-Barr.

W. Burmeister, E. Thierry, P. Morand, 2012, Virologie.

Performance of Two Commercially Available Automated Immunoassays for the Determination of Epstein-Barr Virus Serological Status

J. Seigneurin, M. Buisson, P. Morand, 2012, Clinical and Vaccine Immunology.

Description of an influenza outbreak in a French university hospital and risk factors of nosocomial influenza

M. Mallaret, C. Landelle, J. Bosson, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

M. Buisson, P. Morand, R. Germi, 2021, Frontiers in Microbiology.

A prospective study of Epstein–Barr virus load in 85 hematopoietic stem cell transplants

M. Buisson, H. Chambost, P. Bordigoni, 2002, Bone Marrow Transplantation.

Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation

P. Pouzol, S. Lhomme, S. Larrat, 2017, Bone Marrow Transplantation.

Interaction of Ubinuclein-1, a nuclear and adhesion junction protein, with the 14-3-3 epsilon protein in epithelial cells: implication of the PKA pathway.

W. Burmeister, P. Morand, X. Brazzolotto, 2013, European journal of cell biology.

Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line

P. Mas, P. Morand, V. Boyer, 2014, Virology Journal.

A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis.

O. Genoulaz, J. Seigneurin, S. Fafi-Kremer, 2005, The Journal of infectious diseases.

Quantification of gp350/220 Epstein-Barr virus (EBV) mRNA by real-time reverse transcription-PCR in EBV-associated diseases.

K. Brengel-Pesce, O. Genoulaz, J. Seigneurin, 2004, Clinical chemistry.

Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.

O. Genoulaz, J. Seigneurin, M. Buisson, 1994, The Journal of general virology.

Inhibition of Epstein–Barr virus replication by small interfering RNA targeting the Epstein–Barr virus protease gene

J. Seigneurin, M. Buisson, W. Burmeister, 2008, Antiviral therapy.

Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results

P. Morand, O. Epaulard, J. Giai, 2022, Journal of medical virology.

Time Profile of Viral DNA in Aqueous Humor Samples of Patients Treated for Varicella-Zoster Virus Acute Retinal Necrosis by Use of Quantitative Real-Time PCR

C. Chiquet, J. Romanet, M. Labetoulle, 2013, Journal of Clinical Microbiology.

Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up

D. Raoult, H. Fleury, C. Mengelle, 2004, Journal of Clinical Microbiology.

Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series.

P. Morand, G. Gavazzi, G. Gavazzi, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.

A. Thiébaut, J. Brion, P. Morand, 2014, Antiviral research.

[Cytomegalovirus infection in pregnant women. Seroepidemiological prospective study in 1,018 women in Isere].

C. Cans, P. Jouk, B. Gratacap-Cavallier, 1998, Journal de gynecologie, obstetrique et biologie de la reproduction.

G. Carcelain, N. Dupin, F. Rozenberg, 2009, Archives of dermatology.

New insights into HCV replication in original cells from Aedes mosquitoes

I. Berger, P. Fender, M. Petit, 2017, Virology Journal.

Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.

Vincent Leroy, Véronique Boyer, Patrice Morand, 2009, Journal of virological methods.

Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs

J. Seigneurin, S. Larrat, P. Morand, 2008, Comparative hepatology.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

F. Carrat, C. Degott, S. Pol, 2004, JAMA.

Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

F. Carrat, S. Pol, P. Cacoub, 2007, Journal of acquired immune deficiency syndromes.

[Lymphohistiocytic activation syndrome and Burkholderia cepacia complex infection in a child revealing chronic granulomatous disease and chromosomal integration of the HHV-6 genome].

P. Frange, P. Morand, A. Pagnier, 2011, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy

F. Carrat, S. Pol, P. Cacoub, 2005, Journal of acquired immune deficiency syndromes.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

Ultradeep Pyrosequencing of NS3 To Predict Response to Triple Therapy with Protease Inhibitors in Previously Treated Chronic Hepatitis C Patients

M. Blum, J. Claude, R. Beugnot, 2014, Journal of Clinical Microbiology.

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

F. Carrat, S. Pol, N. Lapidus, 2008, AIDS.

Herpes Simplex Type 2 Encephalitis and Methotrexate Medication: A Fortuitous or Causative Association in a Patient with Spondyloarthritis?

P. Morand, J. Stahl, O. Epaulard, 2016, Antiviral therapy.

Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients

F. Carrat, P. Bedossa, S. Pol, 2008, AIDS.

[Herpes as viewed by the French: result of a survey conducted on 10,000 persons].

B. Dréno, M. Aymard, P. Judlin, 2002, Pathologie-biologie.

Use of TaqStart Antibody to Increase the Sensitivity of Herpesvirus Quantitative PCR on the LightCycler

K. Brengel-Pesce, J. Seigneurin, P. Morand, 2001 .

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease

L. Farinelli, H. Hartung, M. Clerici, 2012, Multiple sclerosis.

Functional determinants of the Epstein-Barr virus protease.

F. Baudin, R. Ruigrok, G. Arlaud, 2001, Journal of molecular biology.

Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD

M. Buisson, G. Socié, J. Dantal, 2017, Scientific Reports.

Genital herpes zoster in an immunocompetent child

P. Morand, M. Leccia, R. Germi, 2020, European Journal of Dermatology.

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD

M. Buisson, P. Morand, E. Drouet, 2022, Pathogens.

Comparison of Commercial Extraction Systems and PCR Assays for Quantification of Epstein-Barr Virus DNA Load in Whole Blood

J. Seigneurin, S. Larrat, P. Morand, 2012, Journal of Clinical Microbiology.

Novel Immunoblot Assay Using Four Recombinant Antigens for Diagnosis of Epstein-Barr Virus Primary Infection and Reactivation

J. Seigneurin, M. Buisson, P. Morand, 1999, Journal of Clinical Microbiology.

Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.

C. Müller, F. Baudin, C. Petosa, 2006, Molecular cell.

First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtype.

P. Simmonds, S. Larrat, P. Morand, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Medical molecular virology.

J. Seigneurin, P. Morand, 1997 .

Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France.

B. Gratacap-Cavallier, J. Seigneurin, P. Morand, 2011, The Journal of infection.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count.

J. Seigneurin, M. Ottmann, P. Morand, 1992, AIDS research and human retroviruses.

Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype.

J. Seigneurin, F. Mallet, P. Morand, 1994, AIDS research and human retroviruses.

Fatal Measles without Rash in Immunocompetent Adult, France

J. Timsit, M. Baccard, P. Morand, 2012, Emerging infectious diseases.

Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.

M. Blum, S. Larrat, P. Morand, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Using high-throughput sequencing for investigating intra-host hepatitis C evolution over long retrospective periods.

M. Blum, S. Larrat, V. Leroy, 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.

P. André, N. Tarbouriech, W. Burmeister, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges

Alban Caporossi, Vincent Leroy, Michael Blum, 2016, Critical reviews in clinical laboratory sciences.

Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment.

P. André, F. Bailly, J. Nana, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Virological Markers in Epstein–Barr Virus-Associated Diseases

P. Morand, O. Epaulard, R. Germi, 2023, Viruses.

Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

D. Costagliola, N. Mounier, F. Bonnet, 2021, AIDS.

Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era.

D. Costagliola, P. Morand, R. Germi, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Evaluation of Whole-Blood Epstein-Barr Viral Load Standardization Using the WHO International Standard

P. Morand, S. Alain, Laurence Grossi, 2016, Journal of Clinical Microbiology.

Methylation of Epstein–Barr virus Rta promoter in EBV primary infection, reactivation and lymphoproliferation

F. de Fraipont, P. Morand, Laurence Grossi, 2016, Journal of medical virology.

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

F. Carrat, S. Pol, P. Cacoub, 2007, AIDS.

Dynamics of Epstein‐Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy

A. Thiébaut, P. Morand, J. Cahn, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.

B. Dréno, P. Morand, O. Epaulard, 2018, Cytotherapy.

Neuroimaging of Epstein-Barr virus infections in children

S. Kremer, S. Fafi-Kremer, P. Morand, 2008, Pediatric Radiology.

Fatal HSV-2 primary infection most likely acquired by kidney transplantation: a case report.

D. Boutolleau, S. Burrel, Johan Noble, 2023, International journal of antimicrobial agents.

Cytomegalovirus infection and kidney transplants: contribution of systematic cytomegalovirus blood detection by antigenemia and polymerase chain reaction.

B. Gratacap-Cavallier, J. Seigneurin, B. Janbon, 1995, Transplantation proceedings.

Fatal case of acute gastroenteritis with multiple viral coinfections☆

P. Pothier, P. Morand, C. Morel-Baccard, 2015, Journal of Clinical Virology.

Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients.

F. Carrat, S. Pol, S. Fafi-Kremer, 2007, Gut.

Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response

S. Fafi-Kremer, A. Paiva, P. Morand, 2014, BMC Cancer.

ReSynPlex: Respiratory Syndrome Linked Pathogens Multiplex Detection and Characterization

C. Marquette, P. Marche, M. Maurin, 2018, IRBM.

Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.

J. Cassuto, N. Sirvent, P. Morand, 2003, Medical and pediatric oncology.

Mumps outbreak and laboratory diagnosis.

P. Morand, J. Stahl, M. Maillet, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Débats et actualités dans le diagnostic virologique de l'herpèsUpdates in the virological diagnosis of herpes infection

P. Morand, B. Chanzy, S. Braig, 2002 .

Is it possible to hospitalize patients in multiple-bed room without increasing the risk of hospital-acquired influenza? Description of a pragmatic preventive strategy in a French university hospital.

M. Mallaret, C. Landelle, S. Larrat, 2021, American journal of infection control.

Epidemiology of Genital Herpes Simplex Virus Infections in a Community-Based Sample in France: Results of the HERPIMAX Study

S. Bertrais, S. Hercberg, K. Ezzedine, 2005, Sexually transmitted diseases.

Three-dimensional structure of the Epstein-Barr virus capsid.

G. Schoehn, G. Effantin, P. Morand, 2012, The Journal of general virology.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A/B virus at emergency department admission: A prospective evaluation during the 2017/2018 influenza season

Maxime Maignan, Caroline Landelle, Patrice Morand, 2019, PloS one.

Performance of an antigen-antibody combined assay for hepatitis C virus testing without venipuncture.

J. Quesada, M. Baccard, S. Larrat, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

An “Anaplastic” Kaposi's Sarcoma Mimicking a Stewart-Treves Syndrome. A Case Report and a Review of Literature

S. Lantuejoul, P. Morand, M. Leccia, 2008, The American Journal of dermatopathology.

Rapid and early virological response to chronic hepatitis C treatment with IFN α2b or PEG-IFN α2b plus ribavirin in HIV/HCV co-infected patients

F. Carrat, S. Pol, S. Fafi-Kremer, 2007, Gut.

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.

F. Carrat, S. Pol, P. Cacoub, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Measles and Secondary Hemophagocytic Lymphohistiocytosis

J. Timsit, P. Morand, J. Lupo, 2012 .

Guillain-Barré syndrome and cytomegalovirus infection during pregnancy.

C. Schwebel, G. Besson, P. Morand, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Effect of a multimodal strategy for prevention of nosocomial influenza: a retrospective study at Grenoble Alpes University Hospital from 2014 to 2019

C. Landelle, J. Bosson, S. Larrat, 2022, Antimicrobial Resistance & Infection Control.

SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study

M. Mallaret, C. Landelle, S. Larrat, 2021, Antimicrobial resistance and infection control.

Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response

D. Bicout, S. Fafi-Kremer, A. Paiva, 2014, BMC Cancer.

Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line

P. Mas, P. Morand, V. Boyer, 2014, Virology Journal.

Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome

R. Gressin, J. Brion, P. Morand, 2008, Scandinavian journal of infectious diseases.

Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

P. Marcellin, G. Duverlie, P. Trimoulet, 2019, Epidemiology and Infection.

Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?

S. Larrat, P. Morand, Christel Laugier, 2021, Journal of Clinical Virology.

Evaluation of the cobas® GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures

S. Larrat, V. Leroy, P. Morand, 2018, PloS one.

Epidemiology of viral encephalitis in 2011.

A. Mailles, P. Morand, J. Stahl, 2011, Medecine et maladies infectieuses.

Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients.

A. Mailles, P. Morand, J. Stahl, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis E Virus Infection in Sheltered Homeless Persons, France

F. Carrat, S. Pol, P. Cacoub, 2012, Emerging infectious diseases.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Infectious encephalitis in elderly patients: a prospective multicentre observational study in France 2016–2019

S. Rheims, C. Diard-Detoeuf, N. Girard, 2022, Infection.

Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury.

J. Seigneurin, P. Morand, J. Zarski, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.